z-logo
open-access-imgOpen Access
The clinical course of non-muscle invasive bladder cancer after transuretral resection of the tumor with or without subsequent intravesical application of bacillus Calmette-Guérin: The influence of patients gender and age
Author(s) -
R. Milošević,
Novak Milović,
Predrag Aleksić,
Miodrag Lazić,
Snežana Cerović,
Rade Prelević,
Aleksandar Spasić,
Dejan Simić,
Božidar Kovačević
Publication year - 2015
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp140616003m
Subject(s) - medicine , statistical significance , bladder cancer , incidence (geometry) , bladder tumor , radiation therapy , clinical significance , resection , urology , cancer , surgery , physics , optics
BACGROUND/AIM: The therapy with intravesical instillation of bacillus Calmette-Guérin (BCG) after transurethral resection (TUR) of tumor is the gold standard of treatment of non-muscle invasive bladder cancer (NMIBC). The role and importance of BCG intravesical therapy in various shape of tumors, were confirmed by our previous investigation. The aim of this study was to examine whether incidence of recurrence and tumor regression differs depending on sex and age of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom